A new oral treatment for psoriatic arthritis, Celgene's Otezla ... able to gain approval for use in psoriasis as well, this will boost its revenues. The drug was filed in Europe in January ...

and BMS says it now plans to launch the new drug later this month, aiming to mount a challenge to Amgen's $2.3 billion oral psoriasis therapy Otezla (apremilast). BMS has previously said it ...

Psoriasis can be painful and interfere with sleep, and people with it may lose confidence in their physical appearance. The ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...

made by Bristol Myers Squibb Co., and Amgen Inc.’s psoriasis drug Otezla. Pfizer said the negotiation process discourages the development of new medicines, but that it will work to protect ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...